These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Mechanisms maintaining enhancement of allografts. I. Demonstration of a specific suppressor cell. Hall BM J Exp Med; 1985 Jan; 161(1):123-33. PubMed ID: 3155790 [TBL] [Abstract][Full Text] [Related]
24. Immunosuppressive properties of antilymphocyte antibody isolated from a specific immunoadsorbent. Wilson BJ; Malley A; Giacometti L; Hill JD Transplantation; 1972 Feb; 13(2):189-92. PubMed ID: 4621776 [No Abstract] [Full Text] [Related]
25. Immunologic comparisons of isolated pancreatic islet and whole-organ allografts. Reckard CR; Stuart FP; Schulak JA Transplant Proc; 1979 Mar; 11(1):563-6. PubMed ID: 109968 [No Abstract] [Full Text] [Related]
26. Protective action of homologous serum component on graft rejection. Hasek M; Karakoz I; Skamene E; Chutna J; Nouza K; Bubenik J; Nemec M; Sovova V Transplant Proc; 1969 Mar; 1(1):527-9. PubMed ID: 4944266 [No Abstract] [Full Text] [Related]
27. Hyperacute rejection of skin allografts in the mouse. Sensitivity of ingrowing skin grafts to the action of alloantibody and rabbit complement. Gerlag PG; Koene RA; Hagemann JF; Wijdeveld PG Transplantation; 1975 Oct; 20(4):308-13. PubMed ID: 1099736 [TBL] [Abstract][Full Text] [Related]
29. The early effects of alloantibody and complement on rat kidney allografts. French ME Transplantation; 1972 May; 13(5):447-51. PubMed ID: 4557794 [No Abstract] [Full Text] [Related]
30. Specific suppression of organ graft rejection. Fabre JW Proc R Soc Med; 1976 Jul; 69(7):528-30. PubMed ID: 785480 [No Abstract] [Full Text] [Related]
31. The beneficial transfusion effect on kidney graft survival attributed to clonal deletion. Terasaki PI Transplantation; 1984 Feb; 37(2):119-25. PubMed ID: 6364494 [No Abstract] [Full Text] [Related]
32. The Cape Western baboon in organ allotransplantation. Murphy GP; Brede HD; Cohen E; Grace JT Transplant Proc; 1970 Dec; 2(4):546-9. PubMed ID: 5000235 [No Abstract] [Full Text] [Related]
33. Enhancement of skin allograft survival by soluble alloantigen is serum-mediated. Rao VS; Bonavida B Transplantation; 1976 Jan; 21(1):42-50. PubMed ID: 1108325 [TBL] [Abstract][Full Text] [Related]
34. Enhanced survival of canine renal allografts of ALS- treated dogs given bone marrow. Caridis DT; Liegeois A; Barrett I; Monaco AP Transplant Proc; 1973 Mar; 5(1):671-4. PubMed ID: 4572126 [No Abstract] [Full Text] [Related]
35. Various effects of alloantibody-containing globulins on the time of retention of skin allografts in the mouse. Harris TN; Harris S; Bocchieri MH; Farber MB; Ogburn CA Transplantation; 1972 Oct; 14(4):495-500. PubMed ID: 4566165 [No Abstract] [Full Text] [Related]
36. The preparation and properties of anti-lymphocytic sera. James K Prog Surg; 1969; 7():140-217. PubMed ID: 4183661 [No Abstract] [Full Text] [Related]
37. Studies on heterologous antilymphocyte serum in mice. VII. Optimal cellular antigen for induction of immunologic tolerance with antilymphocyte serum. Monaco AP; Wood ML Transplant Proc; 1970 Dec; 2(4):489-96. PubMed ID: 4939696 [No Abstract] [Full Text] [Related]
38. The effects of antigen-antibody complexes in allograft rejection. Marquet RL Transplant Proc; 1979 Mar; 11(1):826-9. PubMed ID: 109973 [No Abstract] [Full Text] [Related]
39. Effects of passive enhancement on graft and host. Graft adaptation by alloantibody as the mechanism of prolonged skin allograft survival. McCullough CS; Sugarbaker PH; Matthews W Transplantation; 1984 Jan; 37(1):91-6. PubMed ID: 6229914 [TBL] [Abstract][Full Text] [Related]
40. Preliminary studies on antithymocyte globulin. Orlowski T; SkopiĆska E; Kossowska-Paul B; Wasik M; Wojtulewicz-Kurkus J; Klopotowska E; Tupalska B; Filipowicz Z Pol Med J; 1971; 10(2):400-7. PubMed ID: 4997629 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]